Summit Pharmacy’s Dr. Joel Morton to address upcoming workers’ compensation medication symposium

March 26, 2014

Medical professionals challenged to manage both pain relief and addiction risks

HANOVER, Md., March 26, 2014 /PRNewswire/ — Pain management for injured workers is both a science and an art. Too much medication too often, and a patient can become addicted. Too little, and he or she can suffer needlessly.

That’s the dilemma medical professionals will explore this Thursday at “Medications Gone Wild,” a symposium at Maryland Live! Casino at Arundel Mills. The event is part of the annual workers’ compensation educational series sponsored by MedStar Health, IARP-Chesapeake, and IARP-Virginia.

Dr. Joel Morton, founder, president and medical director of Summit Pharmacy, is a key panelist at the event.

Panel discussions will cover:

    --  Physician repackaging/dispensing
    --  Compounding medications
    --  Opioids
    --  Adjunct medications
    --  Regulatory/legal issues/ethics with medications

“There are creative and medically sound ways to reduce the chance of addiction while still addressing the pain,” said Morton. “These include topical medications and alternatives to opioids. Our pharmacy is innovating in this area, and I look forward to exchanging ideas with my peers at the symposium.”

About Summit Pharmacy, Inc.

Summit Pharmacy, Inc. is the premier workers’ compensation pharmacy, providing unparalleled service to clients throughout the U.S. Founded by Dr. Joel Morton, a former workers’ compensation physician, the company is dedicated to facilitating prescription medication and expediting home medication delivery for patients, as well as managing the claims process for patients, attorneys and doctors. www.summitrx.com


    Jill Searl                                 Lisa Ashley

    Brodeur Partners                           Summit Pharmacy

    jsearl@brodeur.com                         LAshley@summitrx.com

    603.559.5824                               515.422.6988

SOURCE Summit Pharmacy, Inc.

Source: PR Newswire

comments powered by Disqus